ABSTRACT
Introduction .........................................................................................................33 F
-Isoprostanes as Markers of Oxidant Stress
In Vivo
.......................................34 F
-Isoprostanes and Overweight and Obesity ....................................................35 Therapeutic Targets for Reducing Oxidant Stress in Overweight and
Obese Patients ...........................................................................................38 Antioxidants...............................................................................................38
